Pharmaceutical Power Plays: The Hidden Forces Behind the Opioid Crisis
I think what the facts are that at the beginning, somebody had to fund this and industry has the money, and they certainly had an incentive to try to figure out the right way of doing these studies, because doing studies the wrong way is very expensive for industry and it's also expensive for the patients that participate in those trials.
How did the opioid epidemic become such a devastating force in the United States? In this episode of Cover 2 Resources, the mystery unravels as award-winning author Chris McGreal joins host Greg McNeil for the second part of their three-part series on 'American Overdose: The Opioid Tragedy in Three Acts'. They dive deep into the pharmaceutical industry's grip on the FDA, revealing how financial power and strategic studies paved the way for the approval of highly addictive substances.
With insights from key figures like Dr. Nathaniel Katz, former California Congresswoman Mary Bono, Judge Darrell McGraw, and Congressman Hal Rogers, the episode paints a vivid picture of Congress's early but insufficient actions against deceptive pharmaceutical practices. It's a gripping exploration of how profits were prioritized over people's well-being, leading to one of the nation's worst health crises.
Perfect for anyone wanting to understand the intricate web of influence and the legal system's slow response, this episode offers a blend of expert analysis and poignant commentary.